1. The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia 
Yu-Feng Lin, David R. Lairson, Wenyaw Chan, Xianglin L. Du, Kathryn S. Leung, Alana A. Kennedy-Nasser, Caridad A. Martinez, Stephen M. Gottschalk, Catherine M. Bollard, Helen E. Heslop, Malcolm K. Brenner, Robert A. Krance 
Biology of Blood and Marrow Transplantation 
Volume 16, Issue 9, Pages (September 2010)
DOI: /j.bbmt
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
ICER of PBSCT (A) and BMT (B) in the standard-risk subgroup. The ICER was determined using 1000 Monte Carlo simulations to estimate the 95% confidence ellipse. Most points (77%) fell in quadrant II, indicating a higher probability that PBSCT was less effective and more costly than BMT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
ICER of PBSCT (A) and BMT (B) in the high-risk subgroup. The ICER was determined using 1000 Monte Carlo simulations to estimate the 95% confidence ellipse. There is a 37% probability that PBSCT would be less costly but also less effective than BMT (quadrant III). PBSCT has an equivalent opportunity (24%) of being the dominant option (quadrant IV) or being the dominated choice (quadrant II) over BMT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions